Immunogenicity of HIV-1 gp140 - microbicide mixtures in mice using a vaginal delivery model

Documenti analoghi

• P14-06. Phase 1 safety and immunogenicity randomised controlled trial of a vaginal gp140 vaccine
  di: Giemza E, et al.
  Pubblicazione: (2009-10-01)
• Vaginal Delivery of a Recombinant HIV-1 Clade-C Trimeric gp140 within Novel Rheologically Structured Vehicles Induces Specific Immune Responses
  di: Curran, R, et al.
  Pubblicazione: (2008)
• Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer.
  di: Krashias, G, et al.
  Pubblicazione: (2010)
• A novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environment.
  di: Wegmann, F, et al.
  Pubblicazione: (2011)
• A novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environment
  di: Wegmann, F, et al.
  Pubblicazione: (2011)